The association of serum chemerin level with risk of coronary artery disease in Chinese adults

Endocrine

Volumn 41, Issue 2, 2012, Pages 281-288

  Yan, Qun ^a   Zhang, Yifei ^a   Hong, Jie ^a   Gu, Weiqiong ^a   Dai, Meng ^a   Shi, Juan ^a   Zhai, Ying ^a   Wang, Weiqing ^a   Li, Xiaoying ^a   Ning, Guang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemerin; Coronary angiography; Coronary artery disease; Insulin resistance

Indexed keywords

CHEMERIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84862647160     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9550-6     Document Type: Article

References (32)

1. S. Roh, S.H. Song, K.C. Choi, K. Katoh, V. Wittamer, M. Parmentier, S. Sasaki, Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 362, 1013-1018 (2007) (Pubitemid 47390675)
2. K.B. Goralski, T.C. McCarthy, E.A. Hanniman, B.A. Zabel, E.C. Butcher, S.D. Parlee, S. Muruganandan, C.J. Sinal, Chemerin, a novel adipokine that regulate adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 28175-28188 (2007) (Pubitemid 47529521)
3. M.W. Rajala, P.E. Scherer, The adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773 (2003) (Pubitemid 37088727)
4. M.P. Reilly, M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, D.J. Rader, Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932-939 (2005) (Pubitemid 40279897)
5. D.M. Maahs, L.G. Ogden, G.L. Kinney, P. Wadwa, J.K. Snell-Bergeon, D. Dabelea, J.E. Hokanson, J. Ehrlich, R.H. Eckel, M. Rewers, Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111, 747-753 (2005) (Pubitemid 40250635)
6. K. Bozaoglu, K. Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, D. Segal, Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687-4694 (2007) (Pubitemid 47481514)
7. J.L. Cash, R. Hart, A. Russ, J.P. Dixon, W.H. Colledge, J. Doran, A.G. Hendrick, M.B. Carlton, D.R. Greaves, Synthetic chemerinderived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775 (2008) (Pubitemid 351549876)
8. G. Barnea, W. Strapps, G. Herrada, Y. Berman, J. Ong, B. Kloss, R. Axel, K.J. Lee, The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105, 64-69 (2008)
9. B.A. Zabel, S. Nakae, L. Zúñiga, J.Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S.J. Allen, T.M. Handel, C.H. Song, S.J. Galli, E.C. Butcher, Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgEmediated passive cutaneous anaphylaxis. J. Exp. Med. 205, 2207-2220 (2008)
10. T. Yoshimura, J.J. Oppenheim, Chemerin reveals its chimeric nature. J. Exp. Med. 205, 2187-2190 (2008)
11. M. Takahashi, Y. Takahashi, K. Takahashi, F.N. Zolotaryov, K.S. Hong, R. Kitazawa, K. Iida, Y. Okimura, H. Kaji, S. Kitazawa, M. Kasuga, K. Chihara, Chemerin enhances insulin signaling and potentates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582, 573-578 (2008)
12. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, D. Communi, Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175, 487-493 (2005) (Pubitemid 40884353)
13. J. Weigert, M. Neumeier, J. Wanninger, M. Filarsky, S. Bauer, R. Wiest, S. Farkas, M.N. Scherer, A. Schäffler, C. Aslanidis, J. Schölmerich, C. Buechler, Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin. Endocrinol. (Oxf.) 72, 342-348 (2009)
14. M. Lehrke, A. Becker, M. Greif, R. Stark, R.P. Laubender, F. von Ziegler, C. Lebherz, J. Tittus, M. Reiser, C. Becker, B. Göke, A.W. Leber, K.G. Parhofer, U.C. Broedl, Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol. 161, 339-344 (2009)
15. D. Stejskal, M. Karpisek, Z. Hanulova, M. Svestak, Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 152, 217-221 (2008)
16. S.G. Spiroglou, C.G. Kostopoulos, J.N. Varakis, H.H. Papadaki, Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J. Atheroscler. Thromb. 26, 115-130 (2010)
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985) (Pubitemid 15018832)
18. G.G. Gensini, A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 51, 606 (1983) (Pubitemid 13187192)
19. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C.J. Smith, J.A. Spertus, F. Costa, American Heart Association. National Heart, Lung, and Blood Institute: diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112, 2735-2752 (2005) (Pubitemid 41532612)
20. Y.J. Hah, N.K. Kim, M.K. Kim, H.S. Kim, S.H. Hur, H.J. Yoon, Y.N. Kim, K.G. Park, Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab. J. 35, 248-254 (2011)
21. T.C. McCarthy, L.A. Zuniga, B.A. Zabel, E.C. Butcher, C.J. Sinal, The novel adipokine chemerin significantly increases cholesterol uptake in human macrophages. FASEB J. 22, 948 (2008)
22. H. Sell, J. Laurencikiene, A. Taube, K. Eckardt, A. Cramer, A. Horrighs, P. Arner, J. Eckel, Chemerin is a novel adipocytederived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58, 2731-2740 (2009)
23. J. Kaur, R. Adya, B.K. Tan, J. Chen, H.S. Randeva, Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commu. 91, 1762-1768 (2010)
24. K. Bozaoglu, J.E. Curran, C.J. Stocker, M.S. Zaibi, D. Segal, N. Konstantopoulos, S. Morrison, M. Carless, T.D. Dyer, S.A. Cole, H.H. Goring, E.K. Moses, K. Walder, M.A. Cawthorne, J. Blangero, J.B. Jowett, Chemerin, a novel adipokine in the regulation of angiogenesis. J. Clin. Endocrinol. Metab. 95, 2476-2485 (2010)
25. N. Stern, Y. Izkhakov, The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHA. J. Cardiometab. Syndr. 1, 362-363 (2006)
26. Y. Hong, X. Jin, J. Mo, H.M. Lin, Y. Duan, M. Pu, D.L. Wolbrette, D. Liao, Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality-results of prospective analysis for the atherosclerosis risk in communities study. J. Intern. Med. 262, 113-122 (2007)
27. A. Sjöholm, T. Nyström, Endothelial inflammation in insulin resistance. Lancet 365, 610-612 (2005) (Pubitemid 40247919)
28. X. Zhang, L. Ma, F. Peng, Y. Wu, Y. Chen, L. Yu, Z. Lei, C. Zhang, The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population. Endocrine 40, 124-129 (2011)
29. K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.F. Palin, Adiponectin action from head to toe. Endocrine 37, 11-32 (2010)
30. C.V. Desouza, F.G. Hamel, K. Bidasee, K. O'Connellm, Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60, 1286-1294 (2011)
31. C. Gazzaruso, S.B. Solerte, E. De Amici, M. Mancini, A. Pujia, P. Fratino, A. Giustina, A. Garzaniti, Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am. J. Cardiol. 97, 236-239 (2006) (Pubitemid 43139242)
32. C.Gazzaruso,A.Coppola, T.Montalcini,C.Valenti,A.Garzaniti,G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S.B. Solerte, A.Giustina,Erectile dysfunctioncan improve the effectiveness of the current guidelines for the screeningfor asymptomatic coronary artery disease in diabetes. Endocrine 40(2), 273-279 (2011)